Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry.
- N. Carmichael, H. Enzmann, I. Pate, F. Waechter
- Biology, Medicine
- Environmental health perspectives
- 1 November 1997
A survey was performed on the results of 138 carcinogenicity studies conducted in various mouse strains by the agrochemical industry over the period 1983-1993. Data for liver tumor incidence, liver… Expand
Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
- A. Shukla, Jean Grisouard, V. Ehemann, Alexander Hermani, H. Enzmann, D. Mayer
- Biology, Medicine
- Endocrine-related cancer
- 1 June 2009
Insulin and insulin analogs stimulate proliferation of human mammary epithelial cells. We identified and analyzed the signaling pathways related to cell proliferation induced by regular insulin and… Expand
Proliferative effects of insulin analogues on mammary epithelial cells.
- D. Mayer, A. Shukla, H. Enzmann
- Medicine
- Archives of physiology and biochemistry
- 2008
Structural modification of insulin results in the generation of insulin analogues that show altered binding affinities to the insulin receptor and/or IGF-I receptor. As a consequence these insulin… Expand
Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1.
- P. Bannasch, U. Benner, H. Enzmann, H. Hacker
- Biology, Medicine
- Carcinogenesis
- 1 November 1985
In rats treated orally with a single dose of aflatoxin B1 (5 mg/kg body weight) characteristic focal and nodular liver lesions developed which differed in their fine structure, enzyme histochemical… Expand
Significance of Sequential Cellular Changes Inside and Outside Foci of Altered Hepatocytes During Hepatocarcinogenesis∗
- P. Bannasch, H. Enzmann, F. Klimek, E. Weber, H. Zerban
- Biology, Medicine
- Toxicologic pathology
- 1 April 1989
A variety of phenotypic cellular changes emerge in the liver of different species prior to the appearance of hepatocellular adenomas and carcinomas induced by carcinogenic agents (chemicals,… Expand
Committee for Medicinal Products for Human Use (CHMP) guideline on the choice of the non-inferiority margin.
- H. Enzmann
- Medicine
- Statistics in medicine
- 2006
Some of the information contained in this agenda is considered commercially confidential or sensitive and therefore not disclosed. With regard to intended therapeutic indications or procedure scopes… Expand
Market and patient access to new oncology products in Europe: a current, multidisciplinary perspective.
- C. McCabe, L. Bergmann, +12 authors H. Zwierzina
- Medicine
- Annals of oncology : official journal of the…
- 2009
To air challenging issues related to patient and market access to new anticancer agents, the Biotherapy Development Association--an international group focused on developing targeted cancer therapies… Expand
Proliferative effect of Apidra® (insulin glulisine), a rapid-acting insulin analogue on mammary epithelial cells
- A. Shukla, H. Enzmann, D. Mayer
- Biology, Medicine
- Archives of physiology and biochemistry
- 1 July 2009
The structural modification of insulin results in the generation of insulin analogues that show altered binding affinities to the insulin receptor and/or the IGF-I receptor, and as a consequence… Expand
Effects of low doses of N-nitrosomorpholine on the development of early stages of hepatocarcinogenesis.
- H. Enzmann, H. Zerban, A. Kopp-Schneider, E. Loeser, P. Bannach
- Biology, Medicine
- Carcinogenesis
- 1 July 1995
Male Sprague-Dawley rats received the hepatocarcinogen N-nitrosomorpholine (NNM) in the drinking water at low dose levels ranging from 6 mg/l to 60 mg/l for 6 and 12 weeks, respectively. Foci of… Expand
Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblasts
- M. Warnken, U. Reitzenstein, +5 authors K. Racké
- Biology, Medicine
- Naunyn-Schmiedeberg's Archives of Pharmacology
- 6 October 2010
Insulin has been approved for inhaled application, but safety concerns remain, because of un-physiologically high insulin concentrations in the lung. Since insulin may act as growth factor, possible… Expand